Doxorubicin Intracellular Release External UV Irradiation of Dextran--poly(-nitrobenzyl acrylate) Photosensitive Nanoparticles.
Fiche publication
Date publication
mars 2021
Journal
ACS applied bio materials
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VANDERESSE Régis
Tous les auteurs :
El Founi M, Laroui H, Canup BSB, Ametepe JS, Vanderesse R, Acherar S, Babin J, Ferji K, Chevalot I, Six JL
Lien Pubmed
Résumé
In the present study, innovative doxorubicin-loaded nanoparticles (NPs) made of a photosensitive poly(-nitrobenzyl acrylate) (PNBA) hydrophobic matrix and an hydrophilic dextran (Dex) shell were first formulated by the emulsion-solvent evaporation process. Doxorubicin (DOX), a very well-known anticancer drug, was herein chosen as the model. DOX-loaded NPs were successfully produced by covering the hydrophobic PNBA core with Dex chains either physically adsorbed or covalently linked by changing process parameters as the presence of a catalyst (CuBr or CuSO/ascorbic acid). It was then proved that the neutralization of DOX optimized drug loading. DOX loading and release were independent of the coverage mechanism if the catalyst used to covalently link the shell to the core was correctly chosen. Second, the kinetics of DOX release were investigated by simple diffusion or light irradiation of the NPs. Experiments showed that less than 20% of DOX was released by simple diffusion after 48 h in PBS or DMEM media when 45% of DOX released after only 30 s of light irradiation of the NPs. Finally, the impact of the phototriggered DOX release on cell viability was investigated on various cell lines [Caco-2, HepG2, HCT-116, and HT-29 cells as well as murine macrophages (RAW 264.7)]. Cellular mortality was evaluated to be dependent on the cell lines tested. Our approach provided an improved DOX release toward the human liver cancer cell line, and a high internalization of the PNBA-based NPs into HepG2 cells was observed using fluorescence microscopy.
Mots clés
amphiphilic glycopolymer, colorectal cancer, drug delivery system, liver cancer, phototherapy
Référence
ACS Appl Bio Mater. 2021 Mar 15;4(3):2742-2751